By Ethan Covey
A Danish study has concluded that use of the quadrivalent HPV vaccine in pregnant women poses no increased risk for adverse pregnancy outcomes.
The results of their study have been published in The New England Journal of Medicine (2017;376[13]:1223-1233).
The human papillomavirus vaccine is currently recommended for girls and women 9 to 26 years of age. However, few data exist regarding the vaccine’s safety in pregnant women.
“HPV vaccination targeting girls and young